Browse result page of CancerPDF Database
Please click on CancerPDF_ID for detailed information about peptide.
| CancerPDF_ID | Peptide seq | Protein Name | Fluid | Mass/Z | Profiling Technique | Cancer Type | Expression Regulation | PUBMED ID |
|---|---|---|---|---|---|---|---|---|
| CancerPDF_ID1934 | ATEDEGSEQKIPEATNR | Antithrombin-III | Serum | 1873.86536 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1935 | AFLEVNEEGSEAAASTAVVIAGR | Antithrombin-III | Serum | 2290.1441 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1936 | KATEDEGSEQKIPEATNR | Antithrombin-III | Serum | 2001.96033 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1937 | SPEKKATEDEGSEQKIPEATNR | Antithrombin-III | Serum | 2443.18267 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1938 | LQPLDFKENAEQSR | Antithrombin-III | Serum | 1673.8373 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1939 | SKLPGIVAEGRDDLYVSDAFH | Antithrombin-III | Serum | 2288.14371 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1940 | SKLPGIVAEGRDDLYVSDAFHK | Antithrombin-III | Serum | 2416.23867 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1941 | EQLQDMGLVDLFSPEK | Antithrombin-III | Serum | 1847.89752 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1942 | ATEDEGSEQKIPEATN | Antithrombin-III | Serum | 1717.76425 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1943 | EKKATEDEGSEQKIPEATNR | Antithrombin-III | Serum | 2259.09788 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID3073 | LDFKENAEQS | Antithrombin-III | Plasma | 1179.5408 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3074 | LQPLDFKENAEQS | Antithrombin-III | Plasma | 1517.7362 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3075 | SSKLVSANRLFGDK | Antithrombin-III | Plasma | 1520.8311 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3076 | ATEDEGSEQKIPEATN | Antithrombin-III | Plasma | 1717.7642 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3077 | EQLQDMGLVDLFSPEK | Antithrombin-III | Plasma | 1847.8975 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3078 | ATEDEGSEQKIPEATNR | Antithrombin-III | Plasma | 1873.8654 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3079 | KATEDEGSEQKIPEATNR | Antithrombin-III | Plasma | 2001.9603 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3080 | EKKATEDEGSEQKIPEATNR | Antithrombin-III | Plasma | 2259.0979 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3081 | SKLPGIVAEGRDDLYVSDAFH | Antithrombin-III | Plasma | 2288.1437 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3082 | AFLEVNEEGSEAAASTAVVIAGR | Antithrombin-III | Plasma | 2290.1441 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3083 | SKLPGIVAEGRDDLYVSDAFHK | Antithrombin-III | Plasma | 2416.2387 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3084 | SPEKKATEDEGSEQKIPEATNR | Antithrombin-III | Plasma | 2443.1827 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3085 | RVAEGTQVLELPFKGDDITMVLILPKPEK | Antithrombin-III | Plasma | 3235.789 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID4682 | DTISEKTSDQIHFF | Antithrombin-III | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7444 | TISEKTSDQIHFF | Antithrombin-III | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7957 | VLVNTIYFKGL | Antithrombin-III | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID8832 | FLEVNEEGSEA | Antithrombin-III | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID8935 | HGSPVDICTAKPRDIPMNPMC | Antithrombin-III | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID10564 | VDLFSPEKSKLPGIVAEGRDDL | Antithrombin-III | Urine | 2385.2626 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11968 | NVIGTVTSGK | Antithrombin-III | Serum | 974.53966 | LC-MS | Melanoma | "Present in 5 cancer samples out of 8 cancer samples. ,Present in 2 healthy samples out of 4 healthy samples." | 26992070 |
| CancerPDF_ID12304 | STAVVIAGR | Antithrombin-III | Serum | 872.50797 | LC-MS | Melanoma | "Present in 6 cancer samples out of 8 cancer samples. ,Present in 2 healthy samples out of 4 healthy samples." | 26992070 |
| CancerPDF_ID12575 | VIGTVTSGK | Antithrombin-III | Serum | 860.49673 | LC-MS | Melanoma | "Present in 7 cancer samples out of 8 cancer samples. ,Present in 4 healthy samples out of 4 healthy samples." | 26992070 |